Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection
Clinical trial NCT01910636 · COMPLETED
Trial details
- NCT number
- NCT01910636
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-03-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.